TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

4 Stocks Under $10 Making Big Moves
INVESTING

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • Mar 13, 2014 1:30 PM EDT
4 Big-Volume Stocks to Trade for Breakouts: Crocs, Rovi and More
INVESTING

Biotech Stocks on the Verge of Breakouts: Star Scientific

  • By Roberto Pedone
  • Feb 20, 2014 6:00 AM EST
4 Stocks Under $10 Making Big Moves
INVESTING

5 Stocks Under $10 Making Big Moves

  • By Roberto Pedone
  • Jun 7, 2013 7:49 AM EDT
Spectrum Pharma Implodes On Colossal Fusilev Sales Warning
STOCKS

Star Scientific Subpoenaed by U.S. Attorney's Office

  • By Adam Feuerstein
  • Mar 19, 2013 7:00 AM EDT
AbbVie Deserves More Respect
STOCKS

Refuting Star Scientific's Refutation

  • By Adam Feuerstein
  • Jan 29, 2013 9:14 AM EST
The 5 Dumbest Things on Wall Street: Jan. 25
VIDEO

The 5 Dumbest Things on Wall Street: Jan. 25

  • By Gregg Greenberg
  • Jan 25, 2013 10:26 AM EST
[video] Jim Cramer Quick Take: Thoughts on Owning Industrial Stocks
OPINION

The Five Dumbest Things on Wall Street This Week: Jan. 25

  • By Gregg Greenberg
  • Jan 25, 2013 7:00 AM EST
Merck Sales of New Cancer Immunotherapy Top Street Estimates
STOCKS

Star Scientific's Made-Up, Misleading Relationship With Johns Hopkins

  • By Adam Feuerstein
  • Jan 23, 2013 8:51 AM EST
The Next Big Thing in Biotech: Worst CEO Candidates
VIDEO

The Next Big Thing in Biotech: Worst CEO Candidates

  • By Adam Feuerstein
  • Nov 23, 2012 5:00 AM EST
Why Raptor Is Down, Despite Possibility of New Drug Approval
STOCKS

The Fleecing of Star Scientific

  • By Adam Feuerstein
  • Nov 16, 2012 9:27 AM EST
Merck Sales of New Cancer Immunotherapy Top Street Estimates
STOCKS

Star Scientific Admits Legal Defeat, Warns Short on Cash

  • By Adam Feuerstein
  • Nov 12, 2012 5:00 AM EST
SunTrust Leads Bank Stocks Lower
INVESTING

Lockheed Martin, Myrexis: After-Hours Trading

  • By Michael Baron
  • Nov 9, 2012 5:51 PM EST
AbbVie Deserves More Respect
STOCKS

Star Scientific Takes a Magical Mulligan On Failed Study Results

  • By Adam Feuerstein
  • Oct 26, 2012 12:52 PM EDT
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Biotech Stock Mailbag: Catalyst Pharma, Amarin, Star Scientific

  • By Adam Feuerstein
  • Oct 26, 2012 8:00 AM EDT
Merck Sales of New Cancer Immunotherapy Top Street Estimates
STOCKS

Star Scientific's 'Flint' Study Flops

  • By Adam Feuerstein
  • Oct 24, 2012 12:13 PM EDT
Why Raptor Is Down, Despite Possibility of New Drug Approval
STOCKS

Star Scientific: No Mention of Big Cash Payment in RJR Earnings Report (Update)

  • By Adam Feuerstein
  • Oct 23, 2012 11:02 AM EDT
AbbVie Deserves More Respect
STOCKS

Star Scientific Silent on Tobacco Patent Settlement

  • By Adam Feuerstein
  • Oct 4, 2012 9:15 AM EDT
3 Unusual-Volue Stocks on the Rise
INVESTING

5 Stocks Under $10 Set to Soar Higher

  • By Roberto Pedone
  • Sep 27, 2012 1:32 PM EDT
Jim Cramer's 'Mad Money' Recap: Stocks on Sale
JIM CRAMER

Cramer's 'Mad Money' Recap: Looking for an Edge

  • By Scott Rutt
  • Aug 22, 2012 7:56 PM EDT
NewLink Pancreatic Cancer Vaccine Fails, May Even Harm Patients
STOCKS

Biocryst Flu Drug Missing From CDC Guidelines: BioBuzz

  • By Adam Feuerstein
  • Sep 8, 2009 2:27 PM EDT
NewLink Pancreatic Cancer Vaccine Fails, May Even Harm Patients
STOCKS

Spectrum shares fall despite drug approval: BioBuzz

  • By Adam Feuerstein
  • Sep 8, 2009 11:18 AM EDT
Endo International Tumbles as Insys Expects Weak Painkiller Sales
STOCKS

Osiris Stem Cell Drug Fails: BioBuzz

  • By Adam Feuerstein
  • Sep 8, 2009 8:44 AM EDT
STOCKS

Cell Therapeutics Gets Standard Review: BioBuzz

  • By Adam Feuerstein
  • Sep 8, 2009 6:59 AM EDT
Alkermes, Arena: Volume Movers
INVESTING

Friday's Winners & Losers: Star Scientific

  • By TSC Staff
  • Mar 7, 2008 4:32 PM EST
INVESTING

Friday's Small-Cap Winners & Losers

  • By TSC Staff
  • Mar 7, 2008 3:57 PM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.